- Takihata M, Nakamura A, Tajima K Komatsu Y, Tamura H, Yamazaki S, Kondo Y, Yamada M, Kimura M, Terauchi Y. Comparative study of sitagliptin with pioglitazone in Japanese type 2 diabetic patients: the COMPASS randomized controlled trial.Diabetes Obes. Metab., 15(5): 455-62, 2013.
- Maeda H, Kubota A, Kanamori A, Tanaka Y, Terauchi Y, Matsuba I. ASSET-K Study Group. Long-term efficacy and safety of sitagliptin in the treatment of Japanese type 2 diabetes (ASSET-K1) to a target of HbA1c <7%. J Endocrinol Invest, 36(8): 568-73, 2013.
- Ishii H, Terauchi Y, Jinnouchi H, Taketsuna M, Tsuji I, Takeuchi M. Effects of insulin changes on quality of life and glycaemic control in Japanese patients with type 2 diabetes mellitus: the INSIGHTs observational study. J Diabetes Invest, in press, 2013.
- Masuda K, Aoki K, Kamiko K, Takihata M, Ito Y, Nagakura M, Kawasaki S, Akema N, Hasegawa M, Nakajima S, Toumura S, Tsunoda S, Enomoto H, Shimotomai H, Terauchi Y. Glycemic control after addition of the dipeptidyl peptidase-4 inhibitor alogliptin in patients with type 2 diabetes showing inadequate response to thrice-a day treatment with a-glucosidase inhibitors. Expert Opinion on Pharmacotherapy, 14(9):1111-8, 2013.
- Goto A, Morita A, Goto M, Sasaki S, Miyachi M, Aiba N, Kato M, Terauchi Y, Noda M, Watanabe S; for the Saku cohort Study Group. Validity of diabetes self-reports in the Saku Diabetes Study. J Epidemiology, 23(4):295-300, 2013.
- Kondo Y, Satoh S, Nagakura J, Kimura M, Nezu U, Terauchi Y. Defining criteria for the introduction of liraglutide using the glucagon stimulation test in patients with type 2 diabetesJ Diabetes Invest, in press, 2013.
- Nakamura A, Yoneda M, Sumida Y, Eguchi Y, Fujii H, Hyogo H, Ono M, Suzuki Y, Kawaguchi T, Aoki N, Okanoue T, Nakajima A, Maeda S, Terauchi Y. Modification of a simple clinical scoring system as a diagnostic screening tool for nonalcoholic steatohepatitis in Japanese patients with nonalcoholic fatty liver disease.J Diabetes Invest, in press, 2013.
- Tajima K, Shirakawa J, Togashi Y, Inoue H, Sato K, Orime K, Ito Y, Kaji M, Sakamoto E, Nakamura A, Aoki K, Goshima Y, Atsumi T, Terauchi Y. AMPK is involved in the regulation of incretin receptors expression in pancreatic islets under a low glucose concentration.PLoS One. 2013 May 22;8(5):e64633. doi: 10.1371/journal.pone.0064633.
- Masuda K, Kawaguchi J, Aoki K, Yamakawa T, Matsuba I, Terauchi Y. Effect of instruction on caloric intake (25 or 30 kcal/ kg [ideal body weight]/ day) on the degree of glycemic control and improvement of lipid profile in obese patients with type 2 diabetes: a prospective, randomized, controlled, multicenter study (25 or 30 study).J Clin Med Res, 5(5): 368-75, 2013.
- Shirakawa J, Togashi Y, Sakamoto E, Kaji M, Tajima K, Orime K, Inoue H, Kubota N, Kadowaki T, Terauchi Y. Glucokinase activation ameliorates ER stress-induced apoptosis in pancreatic β cells.Diabetes, 62(10): 3448-58, 2013.
- Goto M, Goto A, Morita A, Deura K, Sasaki S, Aiba N, Shimbo T, Terauchi Y, Miyachi M, Noda M, Watanabe S; Saku Cohort Study Group. Low-molecular-weight adiponectin and high-molecular-weight adiponectin levels in relation to diabetes.Obesity (Silver Spring). 2013 Jul 1. doi: 10.1002/oby.20553. [Epub ahead of print]
- Goto A, Arah OA, Goto M, Terauchi Y, Noda M, Severe Hypoglycaemia and Cardiovascular Disease: A Systematic Review and Meta-Analysis with Bias Analysis.BMJ, Jul 29;347:f4533. doi: 10.1136/bmj.f4533.
- Zolzaya K, Nakamura A, Tajima K, Terauchi Y. Role of insulin receptor substrate-1 for diethylnitrosamine plus high-fat diet-induced hepatic tumorigenesis in mice.J Diabetes Invest, in press, 2013
- Takihata M, Nakamura A, Aoki K, Kimura M, Sekino Y, Inamori M, Maeda S, Gotoh E, Nakajima A, Terauchi Y. Comparison of intragastric balloon therapy and intensive lifestyle modification therapy with respect to weight reduction and abdominal fat distribution in super-obese Japanese patients.Obes Res Clin Pract, in press, 2013.
- Tajima K, Nakamura A, Shirakawa J, Togashi Y, Orime K, Sato K, Inoue H, Kaji M, Sakamoto E, Ito Y, Aoki K, Nagashima Y, Atsumi T, Terauchi Y. Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 Mice.Am. J. Physiol. Endocrinol. Metab., 305(8): E987-98, 2013.
- Kawata T, Kanamor A, Kubota A, Maeda H, Matoba K, Jin Y, Ito S, Amamiya H, Takai M, Kaneshige H, Minami N, Minagawa F, Iemitsu K, Kaneshiro M, Hoshino K, Ishikawa M, Takeda H, Motomiya T, Takuma T, Aoyagi S, Mokubo A, Machimura H, Obana M, Miyakawa M, Naka Y, Terauchi Y, Toyoda M, Suzuki D, Tanaka Y, Matsuba I. Clinical Effects of Liraglutide on Diabetes Control in Japanese Type 2 Diabetes Mellitus Patients. Diabetology International, in press
- Orime K, Shirakawa J, Togashi Y, Tajima K, Inoue H, Ito Y, Sato K, Nakamura A, Aoki K, Goshima Y, Terauchi Y. Trefoil factor 2 promotes cell proliferation in pancreatic β cells through CXCR-4-mediated ERK1/2 phosphorylation.Endocrinology, 154(1): 54-64, 2013.
- Nakamura A, Terauchi Y. Lessons from mouse models of high-fat diet-induced NAFLD.Int J Med Sci, 14(11):21240-57, 2013.
- Kawasaki S, Misawa H, Tamura Y, Kondo Y, Satoh S, Hasegawa O, Kato S, Terauchi Y. Relationship between Coronary Artery Disease and Retinopathy in Patients with Type 2 Diabetes Mellitus.Intern Med, 52(22): 2483-7, 2013.
- Ono K, Yamasue K, Tochikubo O, Terauchi Y, Mizushima S. Lifestyle modification system with use of earphone-type thermometer, ABPM and wrist-type pulse rate recorder.Clin Exp Hypertens, in press, 2013.
- Aoki K, Kamiyama H, Masuda K, Kamiko K, Noguchi Y, Tajima K, Terauchi Y. Effects of miglitol, vildagliptin, or their combination on serum insulin and peptide YY levels and plasma glucose, cholecystokinin, ghrelin, and obestatin levels.Endocr J, in press, 2013.
- Nakamura A, Hagiwara E, Hamai J, Taguri M, Terauchi Y. Impact of underlying diabetes and the presence of cavity on the treatment outcomes in patients with pulmonary tuberculosis.Diabetic Medicine, in press, 2013.
- Kato S, Fukui K, Kawaguchi J, Ishii N, Koga M, Kusakawa Y, Kusama I, Nakachi T, Nakagawa T, Terauchi Y, Uchino K, Kimura K, Umemura S. Relationship between coronary flow reserve evaluated by phase-contrast cine cardiovascular magnetic resonance and serum eicosapentaenoic acid.J Cardiovasc Magn Reson. 2013 Dec 20;15(1):106.
